Cargando…

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation

BACKGROUND: Electrical cardioversion (ECV) is a procedure in which a direct current electric shock is used to quickly and effectively restore the normal sinus rhythm. Appropriate anticoagulation reduces the risk of embolic events during and after ECV. The aim of this study was to estimate the cost-e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobs, Maartje S., de Jong, Lisa A., Postma, Maarten J., Tieleman, Robert G., van Hulst, Marinus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105209/ https://www.ncbi.nlm.nih.gov/pubmed/29181817 http://dx.doi.org/10.1007/s10198-017-0942-2

Ejemplares similares

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit
por: Jacobs, Maartje S, et al.
Publicado: (2020)

Left Atrial Appendage Thrombosis During Therapy with Rivaroxaban in Elective Cardioversion for Permanent Atrial Fibrillation
por: Serra, Walter, et al.
Publicado: (2015)

Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands
por: van Hulst, Marinus, et al.
Publicado: (2022)

Screening for Atrial Fibrillation in Sub-Saharan Africa: A Health Economic Evaluation to Assess the Feasibility in Nigeria
por: Jacobs, M. S., et al.
Publicado: (2021)

Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
por: de Jong, Lisa A., et al.
Publicado: (2019)

Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
por: de Jong, Lisa A., et al.
Publicado: (2022)

Sternal fracture after elective electrical cardioversion of atrial fibrillation
por: Vollmann, Dirk, et al.
Publicado: (2010)

Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands
por: Stevanović, Jelena, et al.
Publicado: (2014)

Adjunctive Pharmacotherapy for Elective Direct Current Cardioversion in Patients With Atrial Fibrillation
por: Hirt, Liam S., et al.
Publicado: (2012)

Cost-effectiveness analysis and budget impact of rivaroxaban compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism
por: de Jong, Lisa A, et al.
Publicado: (2020)

Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter
por: Wall, Christopher, et al.
Publicado: (2019)

Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation
por: Forslund, Tomas, et al.
Publicado: (2021)

Absence of significant myocardial injury following elective direct current cardioversion for atrial fibrillation
por: Lobo, Ronstan, et al.
Publicado: (2022)

Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)

Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial
por: Hohnloser, Stefan H., et al.
Publicado: (2016)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Atrial fibrillation cardioversion following acupuncture
por: Dilber, Dario, et al.
Publicado: (2015)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

Rivaroxaban in atrial fibrillation
por: Giorgi, Mariano A, et al.
Publicado: (2012)

Efficacy and Safety of Outpatient Clinic-based Elective External Electrical Cardioversion in Patients with Atrial Fibrillation
por: Son, Nguyen Khac Le, et al.
Publicado: (2020)

Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
por: Wisløff, Torbjørn, et al.
Publicado: (2014)

Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study
por: Hellman, Tapio, et al.
Publicado: (2017)

Current Status of Internal Cardioversion in Atrial Fibrillation
por: Plewan, Andreas, et al.
Publicado: (2002)

Ogilvie's Syndrome following Cardioversion for Atrial Fibrillation
por: Al-Halawani, Moh'd, et al.
Publicado: (2014)

Chemical Cardioversion of Atrial Fibrillation with Calcium Gluconate
por: Serhat, A, et al.
Publicado: (2012)

Timing of cardioversion in atrial fibrillation: the sooner the better?
por: Capranzano, Piera, et al.
Publicado: (2020)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
por: Deuling, J. H. H., et al.
Publicado: (2011)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Serological Predictors for the Recurrence of Atrial Fibrillation After Electrical Cardioversion
por: Kim, Sook Kyoung, et al.
Publicado: (2010)

The RITMIA™ Smartphone App for Automated Detection of Atrial Fibrillation: Accuracy in Consecutive Patients Undergoing Elective Electrical Cardioversion
por: Reverberi, Claudio, et al.
Publicado: (2019)

SAFETY AND EFFICACY OF SAME-DAY ELECTIVE CORONARY ANGIOGRAPHY AND SYNCHRONIZED CARDIOVERSION IN PATIENTS WITH ATRIAL FIBRILLATION WITH UNINTERRUPTED ANTICOAGULATION
por: Gallen, Rory, et al.
Publicado: (2021)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
por: Walsh, Simon J, et al.
Publicado: (2005)

Comparison of monophasic versus biphasic cardioversion for atrial fibrillation
por: Vaisman, M, et al.
Publicado: (2005)

Rare Coronary Embolism Secondary to Cardioversion of Atrial Fibrillation
por: Alkhatib, Deya, et al.
Publicado: (2022)

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
por: Younis, Arwa, et al.
Publicado: (2022)

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients
por: Adedara, Victor O, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ngfbn8qki0tudp3slc1h8j78ii